SavedAdd your journal

Journals / Journal of Contemporary Medicine / 2020 / Cilt: 10 - Sayı: 3

Relationship between platelet counts, mean platelet volume, platecrit and Beta Thalassemia Carriers

Beta Talasemi Taşıyıcılarında Platekrit, Ortalama Trombosit Volümü ve Trombosit Sayısı Arasındaki İlişki

Hatice Tuba AKBAYRAM
Mustafa ÖRKMEZ
Pages
302–306
Publication Date
2020-09-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein we also foundsignificantly elevated platelet counts in BTC with anemia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: β-thalassemia carriers (BTC) is generally asymptomatic;however, in clinical practice, there is hypochromic microcytic mildanemia caused by a hereditary reduction in beta globin synthesis.In the literature, there is also some information about plateletindices in BTC.
📊
Key Findings & Data:In addition, we compared platelet indicesbetween anemia (Hb<11 g/dl) and non-anemia BTC (Hb ≥11 g/dl).Material and Method: A cross sectional study included a totalof 153 subjects aged 1-16 years were recruited from GaziantepUniversity Hospital outpatient clinics electronic database.Results: Platelet counts were normal in 90 patients with BTC.Thrombocytosis and thrombocytopenia were detected in 59(38.5%) and four (2.6%) patients, respectively.
💡
Conclusion & Impact:Herein we also foundsignificantly elevated platelet counts in BTC with anemia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Talasemi · taşıyıcılık · çocuk

Abstract

Aim: β-thalassemia carriers (BTC) is generally asymptomatic;however, in clinical practice, there is hypochromic microcytic mildanemia caused by a hereditary reduction in beta globin synthesis.In the literature, there is also some information about plateletindices in BTC. The aim of this study was to evaluate platelet indicesin children with BTC. In addition, we compared platelet indicesbetween anemia (Hb<11 g/dl) and non-anemia BTC (Hb ≥11 g/dl).Material and Method: A cross sectional study included a totalof 153 subjects aged 1-16 years were recruited from GaziantepUniversity Hospital outpatient clinics electronic database.Results: Platelet counts were normal in 90 patients with BTC.Thrombocytosis and thrombocytopenia were detected in 59(38.5%) and four (2.6%) patients, respectively. This study groupwas divided into two groups as group 1, cases<11 g/dl (n=86), andgroup 2, cases≥11g/dl (n=67) according to the hemoglobin levels.The children with the group 1 had significantly higher mean levelsof platelet counts and platecrit than those with group 2 (p<0.05).In the logistic regression test, linear correlation between plateletcounts and platecrit (r=0.94, p<0.01) was observed, whereas therewere inverse correlations between platelet counts and age (r=-0.32, p<0.01), mean platelet volume (r=-0.18, p<0.05), hemoglobin(r =-0.18, p<0.05).Conclusion: We found that both thrombocytosis andthrombocytopenia may occur in BTC. Herein we also foundsignificantly elevated platelet counts in BTC with anemia.

Özet

Giriş: β-talasemi taşıyıcılığı genellikle asemptomatiktir, bununlaberaber beta globin zincirinde kalıtsal azalmadan dolayı hafifhipokromik mikrositer anemi gelişebilmektedir. Literatürde, talasemitaşıyıcılarında trombosit parametrelerini değerlendiren az sayıdaçalışma bulunmaktadır. Bu çalışmada amacımız talasemi taşıyıcılarındatrombosit parametrelerini değerlendirmektir. Ayrıca çalışmamızdaanemili ve anemisiz talasemi taşıyıcılarında platelet parametrelerinideğerlendirdik.Gereç ve Yöntem: Kesitsel çalışmamızda Gaziantep Üniversitesi TıpFakültesi ayaktan hasta polikliniklerine başvuran 1-16 yaş arası 153talasemi taşıyıcısı çocuk çalışmaya alındı.Bulgular: Doksan çocuğun trombosit sayıları normaldi. 59 (%38.5)çocukta trombositoz, dört (%2.6) çocukta trombositopeni saptandı.Hemoglobin seviyelerine göre iki gruba ayrıldı. Grup 1, hemoglobin<11g/dl (n=86), ve grup 2, hemoglobin≥11g/dl (n=67)’den oluşmaktaydı.Grup 1 olgularda trombosit sayısı ve platekrit, grup 2 olgularındananlamlı olarak yüksekti. (p<0.05) Logistik regresyon testinde trombositsayısı ve platekrit arasında lineer bir korelasyon görüldü (r=0.94,p<0.01), ancak trombosit sayısı ile yaş (r=-0.32, p<0.01), ortalamatrombosit volumü (r=-0.18, p<0.05), hemoglobin (r =-0.18, p<0.05)arasında negatif bir korelasyon görüldü.Sonuç: Talasemi taşıyıcılarında hem trombositoz hemdetrombositopeni olabileceğini bulduk. Ayrıca anemi gelişen talasemitaşıyıcılarında trombosit sayısı anlamlı olarak yüksekti.

🔖

Cite This Article

AKBAYRAM, H. T., ÖRKMEZ, M. (2020). Relationship between platelet counts, mean platelet volume, platecrit and Beta Thalassemia Carriers. Journal of Contemporary Medicine, Cilt: 10 - Sayı: 3, 302–306. https://ajindex.com/articles/775112

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Cascio MJ, DeLoughery TG. Anemia: Evaluation and Diagnostic Tests. Med Clin North Am. 2017
  2. 101(2):263–284. 2- Mettananda S, de Silva DG. Anaemia in children: are we using the correct prevention strategies?. Ceylon Med J. 2017
  3. 62(2):73–76. 3- Yesilipek A, Ertem M, Cetin M, et al. HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: The experience of the Turkish Pediatric Bone Marrow Transplantation Group. Pediatr Transplant. 2012
  4. 16(8):846-51. 4- Bessman JD, Gilmer PR, Gardner FH: Use of platelet volume improves detection of platelet disorders. Blood Cells 1985
  5. 127–135. 5- Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization. 2001
  6. 79(8):704–12. 6- Giambona A, Passarello C, Renda D, et al. The significance of the hemoglobin A(2) value in screening for hemoglobinopathies. Clin Biochem. 2009
  7. 42(18):1786-96. 7- Kadikoylu G, Yavasoglu I, Bolaman Z, Senturk T. Platelet parameters in women with iron deficiency anemia. J Natl Med Assoc 2006
  8. 398–402. 8-Dan K. Thrombocytosis in iron deficiency anemia. Intern Med 2005
  9. 1025–1026. 9-Akan H, Guven N, Aydogdu I, Arat M, Beksac M, Dalva K. Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis. Acta Haematol 2000
  10. 152–156. 10- Mettananda S, Paranamana S, Fernando R, Suranjan M, Rodrigo R1, Perera L, Vipulaguna T, Fernando P, Fernando M, Dayanath BKTP, Costa Y, Premawardhena A. Microcytic anemia in children: parallel screening for iron deficiency and thalassemia provides a useful opportunity for thalassemia prevention in low- and middle-income countries. Pediatr Hematol Oncol. 2020 May
  11. 37(4):326-336. 11- Labib HA, Etewa RL, Atia H. The hypercoagulable status in common Mediterranean β-thalassaemia mutations trait. Int J Lab Hematol. 2015 Jun
  12. 37(3):326-33. 12- Cikrikcioglu MA, Celik K, Ekinci I, Nasifov M, Toprak AE, Cetin G, Genc S. Mean Platelet Volume in Heterozygous Beta Thalassaemia. Acta Haematol. 2017
  13. 137(2):100-105. 13- Levin J, Bessman JD. The inverse relation between platelet volume and platelet number. Abnormalities in hematologic disease and evidence that platelet size does not correlate with platelet age. J Lab Clin Med 1983
  14. 295–307. 14- Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Morb Mortal WklyRepReco